What is IgG (Immunoglobulin G) avidity testing in the context of a pregnant woman with a history of CMV (Cytomegalovirus) and rubella exposure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IgG Avidity Testing

IgG avidity testing measures the strength with which IgG antibodies bind to viral antigens, and it matures gradually over 6 months following primary infection—making it a highly sensitive and specific method to distinguish recent primary CMV or rubella infection from past infection in pregnant women. 1

What Avidity Measures

  • Avidity refers to the binding strength between IgG antibodies and antigenic epitopes on viral proteins 1
  • During primary infection, IgG antibodies initially bind weakly (low avidity), then gradually mature to bind more strongly (high avidity) over approximately 6 months 1
  • This maturation process creates a diagnostic window that allows clinicians to estimate when the primary infection occurred 1

Clinical Interpretation in Pregnancy

Low Avidity Results

  • Low CMV IgG avidity (typically <35-50% depending on assay) indicates primary infection occurred within the preceding 3-4 months 1, 2, 3
  • Low avidity with positive IgM at ≤14 weeks gestation has 83.3% sensitivity and 83.8% specificity for identifying congenital CMV infection risk 2
  • 98.8% of low-avidity samples correspond to infection onset within 180 days before sampling 4

High Avidity Results

  • High CMV IgG avidity (typically >50-60% depending on assay) excludes primary infection within the preceding 3 months 1, 3
  • 77.8% of high-avidity results correspond to infection onset >90 days before sampling 4
  • High avidity in pregnant women indicates past infection with low risk of congenital transmission 5, 6

When to Order Avidity Testing

  • The American College of Obstetricians and Gynecologists recommends IgG avidity testing when both CMV IgG and IgM are positive in pregnant women 5
  • Avidity testing resolves the diagnostic dilemma created by persistent IgM, which can remain positive for months after primary infection or appear during reactivation 1
  • The test is most useful when performed early in pregnancy or soon after suspected exposure, as it becomes less discriminatory later in gestation 2

Diagnostic Algorithm for Pregnant Women

  1. Initial screening: Order CMV IgG and IgM 7
  2. If IgG negative: Patient is susceptible; counsel on prevention 7
  3. If IgG positive alone: Past infection with immunity; low risk of congenital transmission 5, 6
  4. If both IgG and IgM positive: Order IgG avidity testing immediately 5
    • Low avidity = recent primary infection (high risk for fetal transmission) 1, 2
    • High avidity = past infection with false-positive or persistent IgM (low risk) 1, 3

Relationship Between IgM Levels and Avidity

  • Strong CMV IgM reactivity (index ≥3.0) correlates with low avidity in 93-94% of cases 3
  • However, IgM alone has poor specificity because it persists after primary infection and appears during reactivation 1
  • The combination of positive IgM with low avidity at ≤14 weeks gestation provides 99.1% negative predictive value for congenital infection 2

Assay-Specific Considerations

  • Different commercial assays use varying cutoff values for low versus high avidity 4, 3
  • The Elecsys CMV IgG Avidity assay shows 90-97% sensitivity and 89-100% specificity depending on how gray-zone values are handled 4
  • Some assays define low avidity as <35% 2, while others use <50% 3
  • Always interpret results according to the specific assay's validated cutoffs 4

Critical Timing Limitations

  • Avidity testing is only useful when performed at the appropriate time—it cannot detect primary infection if measured too late after seroconversion 2
  • Low IgG avidity loses its predictive value for congenital infection when measured at ≥15 weeks gestation 2
  • The 6-month maturation window means that by late pregnancy, most primary infections will show high avidity 1

Common Pitfalls to Avoid

  • Do not assume negative IgM rules out recent infection—order avidity testing if clinical suspicion remains high despite negative IgM 5
  • Do not rely on avidity testing alone in late pregnancy—it becomes less discriminatory after the first trimester 2
  • Do not interpret avidity results without knowing the specific assay's cutoff values—thresholds vary between manufacturers 4, 3
  • Do not delay amniocentesis in pregnant women with fetal abnormalities based on negative maternal IgM alone—fetal infection can occur with maternal reactivation 5

References

Research

Maternal immunoglobulin G avidity as a diagnostic tool to identify pregnant women at risk of congenital cytomegalovirus infection.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017

Research

Clinical evaluation of the Roche Elecsys CMV IgG Avidity assay.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2014

Guideline

Interpretation and Management of Positive CMV IgG Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Interpretation of Positive CMV IgG Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.